Related Experiment Videos
Ornithine-containing lipid of Bordetella pertussis that carries hemagglutinating activity
Journal of Bacteriology
|November 1, 1982
Abstract:
The proposed structure of the ornithine-containing lipid of Bordetella pertussis is 3-hydroxyhexadecanoic acid amide-linked to ornithine and esterified to the second hexadecanoic acid. The aminolipid strongly agglutinates type A and B human erythrocytes.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.
Journal of clinical pharmacy and therapeutics·2017
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
Transplantation proceedings·2014
Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity.
Drug discoveries & therapeutics·2012
EndD mediates butyrate-dependent toxin release and sporulation in Clostridioides difficile.
Journal of bacteriology·2026
Protein secretion by the type IV pilus machinery in Francisella tularensis.
Journal of bacteriology·2026
Age, Body Mass Index, and Lumbar Trabecular Bone Score in Type 2 Diabetes: Gender-specific Associations.
Journal of imaging informatics in medicine·2026
SPECIES-SPECIFIC MECHANICAL COUPLING DICTATES BIOFILM PERSISTENCE IN E. COLI, S. AUREUS, AND P. AERUGINOSA.
Microbial pathogenesis·2026
Amine-PEG functionalized graphene oxide enhances the mechanical performance and biocompatibility of bovine pericardium for cardiovascular applications.
Nanomedicine : nanotechnology, biology, and medicine·2026
A tuneable diatom biosilica interface for protein corona control and preferential plasma protein adsorption.
Colloids and surfaces. B, Biointerfaces·2026